Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentCell Culture

PUBLISHER: BIS Research | PRODUCT CODE: 1118295

Cover Image

PUBLISHER: BIS Research | PRODUCT CODE: 1118295

Global Recombinant Cell Culture Supplements Market: Focus on Pricing Analysis, Product, Application, Expression System, and Region - Analysis and Forecast, 2022-2032

PUBLISHED:
PAGES: 245 Pages
DELIVERY TIME: 1-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF and Excel (1-3 User License)
USD 5250
PDF and Excel (Global License)
USD 8100

Add to Cart

Description

Table of Contents

List of Tables

“Global Recombinant Cell Culture Supplements Market to Reach $1,188.6 Million by 2032.”

Industry Overview

The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032. The growth in the global recombinant cell culture supplements market is expected to be driven by the rising demand for cell culture supplements, increasing investment in life sciences research and development, as well as growing advantages of recombinant supplements over traditional animal-derived supplements.

Market Lifecycle Stage

The global recombinant cell culture market is increasing at a rapid pace. The growing need for animal-free supplements in cell culture applications is aiding the growth of the recombinant cell culture supplements market. Recombinant cell culture supplements play a crucial role in enhancing cell viability, maintaining a healthy culture, and customizing the cell culture in accordance with the needs of the individual.

Increasing demand for immunotherapy and stem cell and regenerative medicine research is one of the major opportunities in the recombinant cell culture supplements market. Several cell culture companies, and biopharmaceutical companies are working collaboratively on drug development and using recombinant cell culture supplements as a therapeutic means for applications in biological drugs. Furthermore, the market witnessed major mergers and acquisitions in the past four years. For instance, recently, in March 2022, Thermo Fisher Scientific Inc. acquired PeproTech, Inc., a company that specializes in the development and manufacturing of recombinant proteins, in a deal of $1.85 billion.

Impact

Many biopharmaceutical products are being developed by utilizing the cell culture technique. The study of cell physiology and biochemistry is made possible through laboratory cell culture, which also opens up research avenues that are challenging to pursue in vivo. Controlling variables such as the culture media, culture conditions, population density, and growth rate makes it simple to assess the effects of medications or other substances on cultured cells. Additionally, it allows analyzing the function of various genes and offers enormous potential in the field of genetics. It enables the assessment of harmful and carcinogenic chemicals on cells in the fields of oncology and virology and the comprehension of how different medications, viruses, and physical or chemical carcinogens interact. Furthermore, the recombinant cell culture has various applications, such as research on vaccines, stem cells, gene therapy, and genetic engineering, as well as the creation of protein therapies manufacturing of genetically edited proteins such as monoclonal antibodies, insulin, and hormones.

Impact of COVID-19

Due to the pandemic, governments across the globe enforced lockdowns which significantly hampered the research and clinical development of several biopharmaceutical products. Additionally, research grants were shifted toward combating SARS-CoV-2. Further, the biopharmaceutical companies, research, and academic organizations focused on the development of a novel COVID-19 vaccine. Overall, there was some disruption in the recombinant cell culture supplement supply chain and operations in 2020. However, as transportation and marketing were made more accessible, the pandemic's effects on the recombinant cell culture supplements market were minimal to non-existent. Due to the shift in emphasis toward COVID-19 testing, diagnostics, and the supply chain of serum-free or recombinant supplements for the creation of a novel vaccine for the SARS-CoV-2 virus, the companies were able to maintain their financial position.

Market Segmentation

Segmentation 1: by Product

  • Recombinant Albumin (rAlbumin)
  • Recombinant Insulin (rInsulin)
  • Recombinant Epidermal Growth Factor (rEGF)
  • Recombinant Interleukin Growth Factor (rILGF)
  • Recombinant Transferrin (rTransferrin)
  • Recombinant Trypsin (rTrypsin)
  • Recombinant Insulin-like Growth Factor (rIGF)
  • Recombinant Stem Cell Factor (rSCF)
  • Recombinant Aprotinin (rAprotinin)
  • Recombinant Lysozyme (rLysozyme)
  • Others

The global recombinant cell culture supplements market in the products segment is expected to be dominated by recombinant albumin (rAlbumin). Albumin is the major nutrient and is commonly used in all types of cell cultures. Additionally, albumin is used widely in the development of monoclonal antibodies. The increase in demand for mAbs will further increase the utilization of recombinant albumin supplements in cell culture.

Segmentation 2: by Application

  • Stem Cell and Regenerative Medicine
  • Bio-Production
  • Academic and Research Application

In 2021, the global recombinant cell culture supplements market (by application) was dominated by stem cell and regenerative medicine, with a massive market share of 47.95%. However, the fastest growing segment during the forecast period is found to be academic and research applications due to enhanced cell viability and improved batch-to-batch consistency of end products.

Segmentation 3: by Expression System

  • Mammalian
  • E. Coli
  • Yeast
  • Others

The mammalian expression system dominated the global recombinant cell culture supplements market in 2021 with a market share of 40.66%. Most biopharmaceutical companies worldwide utilize stable cell lines derived from mammalian cells to produce biologics.

Segmentation 4: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Rest-of-the-World

The global recombinant cell culture supplements market was dominated by North America in 2021. The growth can be attributed to the presence of prominent players in the region as well as the availability of funding and technology for recombinant cell culture supplements in the region.

Recent Developments in the Global Recombinant Cell Culture Supplements Market

  • In June 2022, Gemini Bioproducts, LLC collaborated with Avantor, Inc. to provide custom cGMP solutions to enhance the process efficiency of hydrated solutions and cell culture media to biopharmaceutical companies.
  • In May 2022, FUJIFILM Irvine Scientific, Inc. announced the completion of its new bioprocessing innovation and collaboration center in China. The new center was to enable local resources and expertise required to optimize cell culture media and workflows to aid the production of vaccines, advanced therapies, and biotherapeutic drug development in China.
  • In March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc. to further enhance and complement its cell culture solutions and expertise in bioprocessing. Furthermore, the acquisition was to provide access to Shenandoah Biotechnology, Inc.'s large portfolio of recombinant proteins, which includes cytokines and growth factors.
  • In December 2019, Sartorius AG acquired a majority stake (~50%) in the Biological Industries and further plans to acquire 20% of the shares within the next three years. This acquisition was to expand Sartorius AG's cell culture media offering and will further complement its existing product portfolio for the companies in a growing market.

Demand - Drivers and Limitations

Following are the demand drivers for the global recombinant cell culture supplements market:

  • Increasing Demand for Recombinant Cell Culture Supplements Due to their Advantages
  • Increased Funding and Investment in Research and Development for Biopharmaceutical Products in Life Sciences Sector
  • Growing Number of Mergers and Acquisitions for Expanding Recombinant Cell Culture Supplements Portfolio
  • Push from Regulatory Bodies to Utilize Animal-Free Media Supplements in Cell Culture Process

The market is expected to face some limitations too due to the following challenges:

  • Challenging Manufacturing Process of Recombinant Proteins
  • Technical Complexities Associated with Recombinant Cell Culture Supplements

How can this report add value to an organization?

  • Product/Innovation Strategy: The product segment helps the reader to understand key recombinant cell culture supplements in the market. Additionally, it helps to understand the multiple applications for which recombinant cell culture supplements are used. Moreover, the study provides the reader with a detailed understanding of different expression systems in which recombinant cell culture supplements are used. These expression systems include mammalian, e. coli, yeast, and others.
  • Growth/Marketing Strategy: The global recombinant cell culture supplements market has seen major development by key players operating in the market, such as mergers and acquisitions, business expansions, and product launches and developments. The favored strategy for the companies has been business expansions. The companies are focusing on the expansion of their manufacturing facilities to optimize and enable rapid and reliable delivery of cell culture media supplements to their customers. For instance, in June 2021, Sartorius AG opened a new site in Beit Haemek, Israel, which would focus on specialty and customized cell culture media for the advanced therapies market.
  • Competitive Strategy: Key players in the global recombinant cell culture supplements market analyzed and profiled in the study involve recombinant cell culture supplements such as recombinant albumin, insulin, and trypsin. Moreover, a detailed competitive benchmarking of players operating in the global recombinant cell culture supplements market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as business expansions, mergers and acquisitions, and partnerships and alliances will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, pipeline product portfolio, and market penetration.

Companies profiled under this section include six public companies and 10 private companies.

Public companies include: Abcam plc., Corning Incorporated, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc., while private companies include BBI Solutions, FUJIFILM Irvine Scientific, Inc., Gemini Bioproducts, LLC, HiMedia Laboratories, InVitria, Kingfisher Biotech, Inc., Novus Biologicals, LLC, R&D Systems, Inc., Sino Biological Inc., and STEMCELL Technologies Inc.

Show more
Product Code: BHP0659SC

Table of Contents

1 Market Overview

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion
  • 1.2 Market Scope
    • 1.2.1 Scope of the Study
    • 1.2.2 Key Questions Answered in the Report
    • 1.2.3 Research Methodology
  • 1.3 Market Overview
    • 1.3.1 Introduction
    • 1.3.2 Cell Culture: Overview
    • 1.3.3 Media and Supplements in Cell Culture Process
      • 1.3.3.1 Serum-Free Media vs. Serum-Containing Media
      • 1.3.3.2 Technological Advancements of Defined Media and Importance of Recombinant Cell Culture Supplements
    • 1.3.4 Overall Process: Cell Development to Biopharmaceutical Product
    • 1.3.5 Pricing Overview
    • 1.3.6 Market Footprint and Growth Potential
  • 1.4 Market Dynamics
    • 1.4.1 Overview
    • 1.4.2 Impact Analysis
    • 1.4.3 Market Drivers
      • 1.4.3.1 Increasing Demand for Recombinant Cell Culture Supplements Due to their Advantages
      • 1.4.3.2 Increased Funding and Investment in Research and Development for Biopharmaceutical Products in Life Sciences Sector
      • 1.4.3.3 Growing Number of Mergers and Acquisitions for Expanding Recombinant Cell Culture Supplements Portfolio
      • 1.4.3.4 Push from Regulatory Bodies to Utilize Animal-Free Media Supplements in Cell Culture Process
    • 1.4.4 Market Restraints
      • 1.4.4.1 Challenging Manufacturing Process of Recombinant Proteins
      • 1.4.4.2 Technical Complexities Associated with Recombinant Cell Culture Supplements
    • 1.4.5 Market Opportunities
      • 1.4.5.1 Increasing Need for Immunotherapies and Stem Cell and Regenerative Medicines
      • 1.4.5.2 Increasing Preference for Serum-Free Media
  • 1.5 Industry Analysis
    • 1.5.1 Regulatory Framework in the U.S.
    • 1.5.2 Regulatory Framework in Europe
    • 1.5.3 Regulatory Scenario Worldwide
  • 1.6 COVID-19 Impact on Global Recombinant Cell Culture Supplements Market
    • 1.6.1 Overview
    • 1.6.2 Research and Clinical Development Interruption in Biopharmaceutical Products
    • 1.6.3 Impact on Research Funding
    • 1.6.4 Conclusion

2 Product, $ Mn, 2021-2032

  • 2.1 Overview
  • 2.2 Recombinant Albumin (rAlbumin)
    • 2.2.1 Recombinant Albumin (rAlbumin) (by Application)
  • 2.3 Recombinant Insulin (rInsulin)
    • 2.3.1 Recombinant Insulin (rInsulin) (by Application)
  • 2.4 Recombinant Epidermal Growth Factor (rEGF)
    • 2.4.1 Recombinant Epidermal Growth Factor (rEGF) (by Application)
  • 2.5 Recombinant Interleukin Growth Factor (rILGF)
    • 2.5.1 Recombinant Interleukin Growth Factor (rILGF) (by Application)
  • 2.6 Recombinant Transferrin (rTransferrin)
    • 2.6.1 Recombinant Transferrin (rTransferrin) (by Application)
  • 2.7 Recombinant Trypsin (rTrypsin)
    • 2.7.1 Recombinant Trypsin (rTrypsin) (by Application)
  • 2.8 Recombinant Insulin-like Growth Factor (rIGF)
    • 2.8.1 Recombinant Insulin-like Growth Factor (rIGF) (by Application)
  • 2.9 Recombinant Stem Cell Factor (rSCF)
    • 2.9.1 Recombinant Stem Cell Factor (rSCF) (by Application)
  • 2.1 Recombinant Aprotinin (rAprotinin)
    • 2.10.1 Recombinant Aprotinin (rAprotinin) (by Application)
  • 2.11 Recombinant Lysozyme (rLysozyme)
    • 2.11.1 Recombinant Lysozyme (rLysozyme) (by Application)
  • 2.12 Others
    • 2.12.1 Recombinant Transforming Growth Factor (rTGF)
    • 2.12.2 Recombinant Insulin-Transferrin-Selenium-Ethanolamine (rITSE)
    • 2.12.3 Recombinant Platelet-Derived Growth Factor (rPDGF)
    • 2.12.4 Recombinant Leukemia Inhibitory Factor (rLIF)
      • 2.12.4.1 Others (by Application)

3 Application, $Mn, 2021-2032

  • 3.1 Overview
  • 3.2 Stem Cell and Regenerative Medicine
    • 3.2.1 Stem Cell Therapies
    • 3.2.2 Cell Therapies
    • 3.2.3 Gene Therapies
  • 3.3 Bio-Production
    • 3.3.1 Monoclonal Antibodies
    • 3.3.2 Recombinant Proteins
    • 3.3.3 Hormones
    • 3.3.4 Vaccines
    • 3.3.5 Other Biological Products
  • 3.4 Academic and Research Application

4 Expression System, $Mn, 2021-2032

  • 4.1 Overview
  • 4.2 Mammalian Expression System
  • 4.3 E. coli Expression System
  • 4.4 Yeast Expression System
  • 4.5 Others

5 Region, $Mn, 2021-2032

  • 5.1 Overview
  • 5.2 North America
    • 5.2.1 Overview
      • 5.2.1.1 North America Recombinant Cell Culture Supplements Market (by Product)
    • 5.2.2 U.S.
    • 5.2.3 Canada
  • 5.3 Europe
    • 5.3.1 Overview
      • 5.3.1.1 Europe Recombinant Cell Culture Supplements Market (by Product)
    • 5.3.2 Germany
    • 5.3.3 U.K.
    • 5.3.4 France
    • 5.3.5 Italy
    • 5.3.6 Spain
    • 5.3.7 Rest-of-Europe
  • 5.4 Asia-Pacific
    • 5.4.1 Overview
      • 5.4.1.1 Asia-Pacific Recombinant Cell Culture Supplements Market (by Product)
    • 5.4.2 China
    • 5.4.3 Japan
    • 5.4.4 India
    • 5.4.5 Australia
    • 5.4.6 South Korea
    • 5.4.7 Rest-of-Asia-Pacific
  • 5.5 Latin America
    • 5.5.1 Overview
      • 5.5.1.1 Latin America Recombinant Cell Culture Supplements Market (by Product)
    • 5.5.2 Brazil
    • 5.5.3 Mexico
    • 5.5.4 Rest-of-Latin America
  • 5.6 Rest-of-the-World
    • 5.6.1 Overview
      • 5.6.1.1 Rest-of-the-World Recombinant Cell Culture Supplements Market (by Product)
    • 5.6.2 Middle East and Africa
    • 5.6.3 Others (Rest-of-the-World)

6 Competitive Landscape

  • 6.1 Overview
  • 6.2 Key Developments and Strategies
    • 6.2.1 Business Expansions
    • 6.2.2 Product Launches and Developments
    • 6.2.3 Mergers and Acquisitions
    • 6.2.4 Others
  • 6.3 Market Share Analysis (by Company)
  • 6.4 Growth-Share Analysis (by Company)

7 Company Profiles

  • 7.1 Overview
  • 7.2 Abcam plc.
    • 7.2.1 Company Overview
    • 7.2.2 Role of Abcam plc. in the Global Recombinant Cell Culture Supplements Market
    • 7.2.3 Key Customers of the Company
    • 7.2.4 Key Competitors of the Company
    • 7.2.5 Financials
    • 7.2.6 Analyst Perspective
  • 7.3 BBI Solutions
    • 7.3.1 Company Overview
    • 7.3.2 Role of BBI Solutions in the Global Recombinant Cell Culture Supplements Market
    • 7.3.3 Key Competitors of the Company
    • 7.3.4 Analyst Perspective
  • 7.4 Corning Incorporated
    • 7.4.1 Company Overview
    • 7.4.2 Role of Corning Incorporated in the Global Recombinant Cell Culture Supplements Market
    • 7.4.3 Key Customers of the Company
    • 7.4.4 Key Competitors of the Company
    • 7.4.5 Financials
    • 7.4.6 Key Insights about Financial Health of the Company
    • 7.4.7 Analyst Perspectives
  • 7.5 FUJIFILM Irvine Scientific, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Role of FUJIFILM Irvine Scientific, Inc. in the Global Recombinant Cell Culture Supplements Market
    • 7.5.3 Key Competitors of the Company
    • 7.5.4 Analyst Perspective
  • 7.6 Gemini Bioproducts, LLC
    • 7.6.1 Company Overview
    • 7.6.2 Role of Gemini Bioproducts, LLC in the Global Recombinant Cell Culture Supplements Market
    • 7.6.3 Key Customers of the Company
    • 7.6.4 Key Competitors of the Company
    • 7.6.5 Analyst Perspective
  • 7.7 HiMedia Laboratories
    • 7.7.1 Company Overview
    • 7.7.2 Role of HiMedia Laboratories in the Global Recombinant Cell Culture Supplements Market
    • 7.7.3 Key Customers of the Company
    • 7.7.4 Key Competitors of the Company
    • 7.7.5 Analyst Perspective
  • 7.8 InVitria
    • 7.8.1 Company Overview
    • 7.8.2 Role of InVitria in the Global Recombinant Cell Culture Supplements Market
    • 7.8.3 Key Customers of the Company
    • 7.8.4 Key Competitors of the Company
    • 7.8.5 Analyst Perspective
  • 7.9 Kingfisher Biotech, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Role of Kingfisher Biotech, Inc. in the Global Recombinant Cell Culture Supplements Market
    • 7.9.3 Key Competitors of the Company
    • 7.9.4 Analyst Perspective
  • 7.1 Lonza Group AG
    • 7.10.1 Company Overview
    • 7.10.2 Role of Lonza Group AG in the Global Recombinant Cell Culture Supplements Market
    • 7.10.3 Key Customers of the Company
    • 7.10.4 Key Competitors of the Company
    • 7.10.5 Financials
    • 7.10.6 Analyst Perspective
  • 7.11 Merck KGaA
    • 7.11.1 Company Overview
    • 7.11.2 Role of Merck KGaA in the Global Recombinant Cell Culture Supplements Market
    • 7.11.3 Key Customers of the Company
    • 7.11.4 Key Competitors of the Company
    • 7.11.5 Financials
    • 7.11.6 Key Insights about Financial Health of the Company
    • 7.11.7 Analyst Perspective
  • 7.12 Novus Biologicals, LLC
    • 7.12.1 Company Overview
    • 7.12.2 Role of Novus Biologicals, LLC in the Global Recombinant Cell Culture Supplements Market
    • 7.12.3 Key Customers of the Company
    • 7.12.4 Key Competitors of the Company
    • 7.12.5 Analyst Perspective
  • 7.13 R&D Systems, Inc.
    • 7.13.1 Company Overview
    • 7.13.2 Role of R&D Systems, Inc. in the Global Recombinant Cell Culture Supplements Market
    • 7.13.3 Key Customers of the Company
    • 7.13.4 Key Competitors of the Company
    • 7.13.5 Analyst Perspective
  • 7.14 Sartorius AG
    • 7.14.1 Company Overview
    • 7.14.2 Role of Sartorius AG in the Global Recombinant Cell Culture Supplements Market
    • 7.14.3 Key Customers of the Company
    • 7.14.4 Key Competitors of the Company
    • 7.14.5 Financials
    • 7.14.6 Key Insights about Financial Health of the Company
    • 7.14.7 Analyst Perspective
  • 7.15 Sino Biological Inc.
    • 7.15.1 Company Overview
    • 7.15.2 Role of Sino Biological Inc. in the Global Recombinant Cell Culture Supplements Market
    • 7.15.3 Key Customers of the Company
    • 7.15.4 Key Competitors of the Company
    • 7.15.5 Analyst Perspective
  • 7.16 STEMCELL Technologies Inc.
    • 7.16.1 Company Overview
    • 7.16.2 Role of STEMCELL Technologies Inc. in the Global Recombinant Cell Culture Supplements Market
    • 7.16.3 Key Customers of the Company
    • 7.16.4 Key Competitors of the Company
    • 7.16.5 Analyst Perspective
  • 7.17 Thermo Fisher Scientific Inc.
    • 7.17.1 Company Overview
    • 7.17.2 Role of Thermo Fisher Scientific Inc. in the Global Recombinant Cell Culture Supplements Market
    • 7.17.3 Key Customers of the Company
    • 7.17.4 Key Competitors of the Company
    • 7.17.5 Financials
    • 7.17.6 Key Insights about Financial Health of the Company
    • 7.17.7 Analyst Perspective
Show more
Product Code: BHP0659SC

List of Figures

  • Figure 1: Global Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Recombinant Cell Culture Supplements Market
  • Figure 3: Global Recombinant Cell Culture Supplements Market (Share by Product), 2021 and 2032
  • Figure 4: Global Recombinant Cell Culture Supplements Market (Share by Application), 2021 and 2032
  • Figure 5: Global Recombinant Cell Culture Supplements Market (Share by Expression System), 2021 and 2032
  • Figure 6: Global Recombinant Cell Culture Supplements Market (Share by Region), 2021 and 2032
  • Figure 7: Global Recombinant Cell Culture Supplements Market
  • Figure 8: Global Recombinant Cell Culture Supplements Market: Research Methodology
  • Figure 9: Primary Research Methodology
  • Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 11: Initial Stages of Cell Culture
  • Figure 12: Advantages of Serum-Free Media
  • Figure 13: Recombinant Cell Culture Supplements and Applications
  • Figure 14: Development of Biopharmaceutical Product: Cell Culture Process
  • Figure 15: Global Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 16: Number of Mergers and Acquisitions in Recombinant Cell Culture Supplements Market, 2019-2022
  • Figure 17: Food and Drugs Administration (FDA) Approved Monoclonal Antibodies (mAbs), 2015-2020
  • Figure 18: Clinical Development Landscape (Drug Pipeline) for Regenerative Medicine in the U.S. (February 2020)
  • Figure 19: Food and Drug Administration's Role
  • Figure 20: Cell and Tissue Culture Supplies and Equipment
  • Figure 21: European Union (EU) Guidelines for Animal-Derived Media
  • Figure 22: Areas of Disruption in Clinical Development
  • Figure 23: Positive Impact of COVID-19: Global Recombinant Cell Culture Supplements Market
  • Figure 24: Segmentation of Recombinant Cell Culture Supplements Market
  • Figure 25: Global Recombinant Cell Culture Supplements Market (by Product), $Million, 2021 and 2032
  • Figure 26: Global Recombinant Cell Culture Supplement Market (Recombinant Albumin (rAlbumin)), $Million, 2021-2032
  • Figure 27: Global Recombinant Cell Culture Supplements Market (Recombinant Albumin (rAlbumin), by Application), $Million, 2021-2032
  • Figure 28: Global Recombinant Cell Culture Supplements Market (Recombinant Albumin (rAlbumin), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 29: Global Recombinant Cell Culture Supplements Market (Recombinant Albumin (rAlbumin), by Bio-Production), $Million, 2021-2032
  • Figure 30: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin)), $Million, 2021-2032
  • Figure 31: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin), by Application), $Million, 2021-2032
  • Figure 32: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 33: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin (rInsulin), by Bio-Production), $Million, 2021-2032
  • Figure 34: Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF)), $Million, 2021-2032
  • Figure 35: Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF), by Application), $Million, 2021-2032
  • Figure 36: Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 37: Global Recombinant Cell Culture Supplements Market (Recombinant Epidermal Growth Factor (rEGF), by Bio-Production), $Million, 2021-2032
  • Figure 38: Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF)), $Million, 2021-2032
  • Figure 39: Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF), by Application), $Million, 2021-2032
  • Figure 40: Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 41: Global Recombinant Cell Culture Supplements Market (Recombinant Interleukin Growth Factor (rILGF), by Bio-Production), $Million, 2021-2032
  • Figure 42: Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin)), $Million, 2021-2032
  • Figure 43: Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin), by Application), $Million, 2021-2032
  • Figure 44: Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 45: Global Recombinant Cell Culture Supplements Market (Recombinant Transferrin (rTransferrin), by Bio-Production), $Million, 2021-2032
  • Figure 46: Recombinant Trypsin (rTrypsin): Common Features
  • Figure 47: Global Recombinant Cell Culture Supplements Market (Recombinant Trypsin (rTrypsin)), $Million, 2021-2032
  • Figure 48: Global Recombinant Cell Culture Supplements Market (Recombinant Trypsin (rTrypsin), by Application), $Million, 2021-2032
  • Figure 49: Global Recombinant Trypsin (rTrypsin) Market (by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 50: Global Recombinant Cell Culture Supplements Market (Recombinant Trypsin (rTrypsin), by Bio-Production), $Million, 2021-2032
  • Figure 51: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF)), $Million, 2021-2032
  • Figure 52: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF), by Application), $Million, 2021-2032
  • Figure 53: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 54: Global Recombinant Cell Culture Supplements Market (Recombinant Insulin-like Growth Factor (rIGF), by Bio-Production), $Million, 2021-2032
  • Figure 55: Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), $Million, 2021-2032
  • Figure 56: Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), by Application), $Million, 2021-2032
  • Figure 57: Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 58: Global Recombinant Cell Culture Supplements Market (Recombinant Stem Cell Factor (rSCF), by Bio-Production), $Million, 2021-2032
  • Figure 59: Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin), $Million, 2021-2032
  • Figure 60: Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin), by Application), $Million, 2021-2032
  • Figure 61: Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin) Market, by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 62: Global Recombinant Cell Culture Supplements Market (Recombinant Aprotinin (rAprotinin), by Bio-Production), $Million, 2021-2032
  • Figure 63: Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme)), $Million, 2021-2032
  • Figure 64: Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme), by Application), $Million, 2021-2032
  • Figure 65: Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme), by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 66: Global Recombinant Cell Culture Supplements Market (Recombinant Lysozyme (rLysozyme), by Bio-Production), $Million, 2021-2032
  • Figure 67: Global Recombinant Cell Culture Supplements Market (Others), $Million, 2021-2032
  • Figure 68: Global Recombinant Cell Culture Supplements Market (Others, by Application), $Million, 2021-203
  • Figure 69: Global Recombinant Cell Culture Supplements Market (Others, by Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 70: Global Recombinant Cell Culture Supplements Market (Others, by Bio-Production), $Million, 2021-2032
  • Figure 71: Global Recombinant Cell Culture Supplements (by Application)
  • Figure 72: Global Recombinant Cell Culture Supplements Market (by Application), 2022 and 2032
  • Figure 73: Regenerative Medicine: Present and Future State
  • Figure 74: Global Recombinant Cell Culture Supplements Market (Stem Cell and Regenerative Medicine), $Million, 2021-2032
  • Figure 75: Global Recombinant Cell Culture Supplements Market (by Stem Cell and Regenerative Medicine), $Million, 2021 and 2032
  • Figure 76: Types of Stem Cells
  • Figure 77: Global Recombinant Cell Culture Supplements Market (Stem Cell Therapies), $Million, 2021-2032
  • Figure 78: Type of Cell Therapies
  • Figure 79: Global Recombinant Cell Culture Supplements Market (Cell Therapies), $Million, 2021-2032
  • Figure 80: Type of Gene Therapies
  • Figure 81: Global Recombinant Cell Culture Supplements Market (Gene Therapies), $Million, 2021-2032
  • Figure 82: Global Recombinant Cell Culture Supplements Market (by Bio-Production), $Million, 2021-2032
  • Figure 83: Global Recombinant Cell Culture Supplements Market (by Bio-Production), $Million, 2021 and 2032
  • Figure 84: Global Recombinant Cell Culture Supplements Market (Monoclonal Antibodies), $Million, 2021-2032
  • Figure 85: Global Recombinant Cell Culture Supplements Market (Recombinant Proteins), $Million, 2021-2032
  • Figure 86: Global Recombinant Cell Culture Supplements Market (Hormones), $Million, 2021-2032
  • Figure 87: Global Recombinant Cell Culture Supplements Market (Vaccines), $Million, 2021-2032
  • Figure 88: Global Recombinant Cell Culture Supplements Market (Other Biological Products), $Million, 2021-2032
  • Figure 89: Recombinant Supplement and Respective Applications
  • Figure 90: Global Recombinant Cell Culture Supplements Market (Academic and Research Application), $Million, 2021-2032
  • Figure 91: Global Recombinant Cell Culture Supplements Market (by Expression System), $Million, 2021 and 2032
  • Figure 92: Global Recombinant Cell Culture Supplements Market (Mammalian Expression System), $Million, 2021-2032
  • Figure 93: Global Recombinant Cell Culture Supplements Market (E. coli Expression System), $Million, 2021-2032
  • Figure 94: Global Recombinant Cell Culture Supplements Market (Yeast Expression System), $Million, 2021-2032
  • Figure 95: Global Recombinant Cell Culture Supplements Market (Others), $Million, 2021-2032
  • Figure 96: Global Recombinant Cell Culture Supplements Market (by Region), $Million, 2021 and 2032
  • Figure 97: North America Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 98: North America: Market Dynamics
  • Figure 99: North America Recombinant Cell Culture Supplements Market (by Country), $Million, 2021 and 2032
  • Figure 100: U.S. Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 101: Canada Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 102: Europe Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 103: Europe: Market Dynamics
  • Figure 104: Europe Recombinant Cell Culture Supplements Market (by Country), $Million, 2021 and 2032
  • Figure 105: Germany Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 106: U.K. Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 107: France Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 108: Italy Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 109: Spain Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 110: Rest-of-Europe Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 111: Asia-Pacific Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 112: Asia-Pacific: Market Dynamics
  • Figure 113: Asia-Pacific Recombinant Cell Culture Supplements Market (by Country), $Million, 2021 and 2032
  • Figure 114: China Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 115: Japan Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 116: India Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 117: Australia Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 118: South Korea Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 119: Rest-of-Asia-Pacific Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 120: Latin America Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 121: Latin America: Market Dynamics
  • Figure 122: Latin America Recombinant Cell Culture Supplements Market (by Country), $Million, 2021-2032
  • Figure 123: Brazil Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 124: Mexico Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 125: Rest-of-Latin America Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 126: Rest-of-the-World (RoW) Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 127: Rest-of-the-World Recombinant Cell Culture Supplements Market (by Region), $Million, 2021-2032
  • Figure 128: Middle East and Africa Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 129: Middle East and Africa: Market Dynamics
  • Figure 130: Others (Rest-of-the-World) Recombinant Cell Culture Supplements Market, $Million, 2021-2032
  • Figure 131: Competitive Landscape (January 2019-June 2022)
  • Figure 132: Share of Key Developments and Strategies, January 2019-June 2022
  • Figure 133: Business Expansions (by Company), January 2019-June 2022
  • Figure 134: Product Launches and Developments (by Company), January 2019-June 2022
  • Figure 135: Mergers and Acquisitions (by Company), January 2019-June 2022
  • Figure 136: Others (by Company), January 2019-June 2022
  • Figure 137: Market Share Analysis of Global Recombinant Cell Culture Supplements Market (by Company), 2020 and 2021
  • Figure 138: Growth-Share Analysis for Global Recombinant Cell Culture Supplements (by Company), 2021
  • Figure 139: Share of Total Number of Companies Profiled
  • Figure 140: Abcam plc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 141: Abcam plc.: Overall Financials, $Million, 2018-2020
  • Figure 142: Abcam plc.: Revenue (by Region), $Million, 2018-2020
  • Figure 143: BBI Solutions: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 144: Corning Incorporated: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 145: Corning Incorporated: Overall Financials, $Million, 2019-2021
  • Figure 146: Corning Incorporated: Revenue (by Segment), $Million, 2019-2021
  • Figure 147: Corning Incorporated: Revenue (by Region), $Million, 2019-2021
  • Figure 148: Corning Incorporated: R&D Expenditure, $Million, 2019-2021
  • Figure 149: FUJIFILM Irvine Scientific, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 150: Gemini Bioproducts, LLC : Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 151: HiMedia Laboratories: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 152: InVitria: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 153: Kingfisher Biotech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 154: Lonza Group AG: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 155: Lonza Group AG: Overall Financials, $Million, 2019-2021
  • Figure 156: Lonza Group AG: Revenue (by Segment), $Million, 2019-2021
  • Figure 157: Merck KGaA: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 158: Merck KGaA: Overall Financials, $Million, 2019-2021
  • Figure 159: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
  • Figure 160: Merck KGaA: Revenue (by Region), $Million, 2019-2021
  • Figure 161: Merck KGaA: R&D Expenditure, $Million, 2019-2021
  • Figure 162: Novus Biologicals, LLC: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 163: R&D Systems, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 164: Sartorius AG: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 165: Sartorius AG: Overall Financials, $Million, 2019-2021
  • Figure 166: Sartorius AG: Revenue (by Segment), $Million, 2019-2021
  • Figure 167: Sartorius AG: Revenue (by Region), $Million, 2019-2021
  • Figure 168: Sartorius AG: R&D Expenditure, $Million, 2019-2021
  • Figure 169: Sino Biological Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 170: STEMCELL Technologies Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 171: Thermo Fisher Scientific Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 172: PeproTech, Inc.: Product Portfolio for Global Recombinant Cell Culture Supplements Market
  • Figure 173: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
  • Figure 174: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021
  • Figure 175: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 176: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021

List of Tables

  • Table 1: Types of Cell Culture Media
  • Table 2: Pricing Overview: Recombinant Cell Culture Supplements
  • Table 3: Likert Scale
  • Table 4: Impact Analysis of Market Drivers
  • Table 5: Impact Analysis of Market Restraints
  • Table 6: Impact Analysis of Market Opportunities
  • Table 7: Cost of Goods Analysis for Manufacturing of Cell Therapy Per Process
  • Table 8: Regulatory Scenario: Worldwide
  • Table 9: Some Companies Offering Recombinant Albumin (rAlbumin) Products
  • Table 10: Some Companies Offering Recombinant Insulin (rInsulin) Products
  • Table 11: Some Companies Offering Recombinant Epidermal Growth Factor (rEGF) Products
  • Table 12: Some Companies Offering Recombinant Interleukin Growth Factor (rILGF) Products
  • Table 13: Some Companies Offering Recombinant Transferrin (rTransferrin) Products
  • Table 14: Some Companies Offering Recombinant Trypsin (rTrypsin) Products
  • Table 15: Some Companies Offering Recombinant Insulin-like Growth Factor (rIGF) Products
  • Table 16: Some Companies Offering Recombinant Stem Cell Factor (rSCF) Products
  • Table 17: Some Companies Offering Recombinant Aprotinin (rAprotinin) Products
  • Table 18: Some Companies Offering Recombinant Lysozyme (rLysozyme) Products
  • Table 19: Some Companies Offering Other Supplement Products
  • Table 20: North America Recombinant Cell Culture Supplements Market (by Product), 2021-2032
  • Table 21: Europe Recombinant Cell Culture Supplements Market (by Product), 2022-2032
  • Table 22: Asia-Pacific Recombinant Cell Culture Supplements Market (by Product), 2022-2032
  • Table 23: Latin America Recombinant Cell Culture Supplements Market (by Product), 2022-2032
  • Table 24: Rest-of-the-World Recombinant Cell Culture Supplements Market (by Product), 2022-2032
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!